LADENBURG THALMANN FINANCIAL SERVICES INC. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$15,000
+50.0%
324
+4.5%
0.00%
Q3 2019$10,000
-33.3%
3100.0%0.00%
Q2 2019$15,000
-34.8%
310
-7.2%
0.00%
Q1 2019$23,000
+53.3%
334
+2.8%
0.00%
Q4 2018$15,000
+1400.0%
325
+3150.0%
0.00%
Q3 2018$1,000
-88.9%
10
-93.3%
0.00%
Q1 2017$9,000
+80.0%
150
+18.1%
0.00%
Q2 2016$5,000
-54.5%
127
-53.3%
0.00%
Q1 2016$11,000
-15.4%
272
+34.7%
0.00%
Q4 2015$13,000
-7.1%
202
-1.5%
0.00%
Q3 2015$14,000
-39.1%
205
-2.8%
0.00%
Q2 2015$23,000
+15.0%
2110.0%0.00%
Q1 2015$20,000
+150.0%
211
+197.2%
0.00%
Q4 2014$8,000
+100.0%
710.0%0.00%
Q3 2014$4,000
+33.3%
710.0%0.00%
Q2 2014$3,000710.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$80,873,00075.24%
Casdin Capital, LLC 187,500$7,855,0007.82%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 40,000$1,676,0004.87%
BB BIOTECH AG 2,363,321$99,011,0003.91%
AlpInvest Partners B.V. 30,000$1,257,0002.49%
Opaleye Management Inc. 85,000$3,561,0002.38%
Opus Point Partners Management, LLC 43,295$1,814,0001.75%
Clarius Group, LLC 47,666$1,997,0001.06%
CAPITAL INTERNATIONAL LTD /CA/ 260,600$10,918,0000.79%
Eventide Asset Management 300,800$12,602,0000.77%
View complete list of AGIOS PHARMACEUTICALS INC shareholders